13F Data
13F filer · CIK 2038158

NEXTBio Capital Management LP

AUSTIN, TX · filing since Q4 2025 · last filing Aug 14, 2026
Reported value
$217.4M
+$2.0M vs prior
Positions
22
New / sold out
3 / 5
Added / reduced
7 / 5
Turnover
13.0%
buys $28.2M · sells $52.3M
Top-10 weight
77.7%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedSTRUCTURE THERAPEUTICS INC+179,257+134.5%+$9.6M
AddedSHATTUCK LABS INC+577,441+18.3%+$4.0M
NewPHARVARIS N V+108,055–+$3.7M
NewBIOAGE LABS INC+100,732–+$2.5M
NewLB PHARMACEUTICALS INC+68,249–+$2.2M
AddedORIC PHARMACEUTICALS INC+182,505+34.9%+$2.0M
AddedINVENTIVA SA+454,500+34.1%+$1.7M
AddedPALVELLA THERAPEUTICS INC NE+7,223+8.7%+$1.1M
AddedVAXCYTE INC+12,000+12.6%+$697.6K
AddedRHYTHM PHARMACEUTICALS INC+5,680+4.5%+$630.7K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outTERNS PHARMACEUTICALS INC-604,534-100.0%$-31.9M
Sold outCOMPASS THERAPEUTICS INC-848,204-100.0%$-4.5M
Sold outOCULIS HOLDING AG-149,592-100.0%$-4.0M
ReducedCOMPASS PATHWAYS PLC-245,648-12.2%$-3.5M
Sold outKALVISTA PHARMACEUTICALS INC-131,796-100.0%$-2.7M
ReducedVOR BIOPHARMA INC-110,803-11.1%$-2.0M
Sold outSUMMIT THERAPEUTICS INC-89,717-100.0%$-1.7M
ReducedPROTAGONIST THERAPEUTICS INC-10,286-4.5%$-1.3M
ReducedEVOMMUNE INC-65,000-35.3%$-863.8K
ReducedCOGENT BIOSCIENCES INC-113-0.1%$-4.4K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2025: $170.5MQ1 2026: $215.4MQ2 2026: $217.4M
Q4 2025Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1PROTAGONIST THERAPEUTICS INCCOM219,333$26.9M12.37%
2SHATTUCK LABS INCCOM3,727,348$25.9M11.90%
3COMPASS PATHWAYS PLCSPONSORED ADS1,775,759$25.1M11.56%
4STRUCTURE THERAPEUTICS INCSPONSORED ADS312,496$16.8M7.71%
5VOR BIOPHARMA INCCOM NEW889,164$16.4M7.53%
6RHYTHM PHARMACEUTICALS INCCOM131,758$14.6M6.73%
7PALVELLA THERAPEUTICS INC NECOM89,909$13.7M6.32%
8XENON PHARMACEUTICALS INCCOM183,225$11.1M5.09%
9ZENAS BIOPHARMA INCCOM426,736$10.8M4.98%
10ORIC PHARMACEUTICALS INCCOM706,124$7.6M3.52%
12 more rows. Subscribe for $29/month to see every row, download the data and use the API.